Last reviewed · How we verify
Dexamethasone Phosphate Ophthalmic Solution — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Dexamethasone Phosphate Ophthalmic Solution (Dexamethasone Phosphate Ophthalmic Solution) — Eyegate Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dexamethasone Phosphate Ophthalmic Solution TARGET | Dexamethasone Phosphate Ophthalmic Solution | Eyegate Pharmaceuticals, Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dexamethasone Phosphate Ophthalmic Solution CI watch — RSS
- Dexamethasone Phosphate Ophthalmic Solution CI watch — Atom
- Dexamethasone Phosphate Ophthalmic Solution CI watch — JSON
- Dexamethasone Phosphate Ophthalmic Solution alone — RSS
Cite this brief
Drug Landscape (2026). Dexamethasone Phosphate Ophthalmic Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/dexamethasone-phosphate-ophthalmic-solution. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab